Small business fee waivers or discounts may be coming for generic drug makers, but it likely will be at the expense of larger companies.
Generic drug user fee reauthorization discussions have moved to dealing with a congressional directive to "consider relief for small businesses,"...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?